
Adjuvant Pembrolizumab (NSCLC), Elacestrant, & Pirtobrutinib
OncoPharm
00:00
Adjuvant Chemotherapy Context and Outcomes
John emphasizes benefit seen only in patients who received adjuvant chemo and discusses implications for micro-metastatic disease.
Play episode from 03:52
Transcript


